Boris Brill
Impact in
- Virology top 10%
- HIV Research and Treatment
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments
Papers in
- Oncology 16
- Cytokine Signaling Pathways and Interactions 9
- Cancer Cells and Metastasis 4
- CAR-T cell therapy research 3
- Immunology 10
- Immune Cell Function and Interaction 4
- T-cell and B-cell Immunology 4
- Co-authors
- Bernd Groner (16 shared papers)Corina Borghouts (8 shared papers)Vida Vafaizadeh (5 shared papers)Ursula Dietrich (3 shared papers)Judith Bergs (2 shared papers)Franz Rödel (2 shared papers)Anja Waldmann (1 shared paper)Winfried S. Wels (1 shared paper)
- Journals
- Hormone Molecular Biology and Clinical Investigation (4 papers)Minerva Urology and Nephrology (1 paper)Nutrients (1 paper)Molecular Cancer Research (1 paper)Pharmaceuticals (1 paper)
- Partner nations
- GermanyUnited StatesIsrael
In The Last Decade
Boris Brill
35 papers receiving 696 citations
Peers
Comparison fields: 5 of 79
- Virology 51
- Hematology 114
- Immunology 173
- Cancer Research 102
- Oncology 166
Countries citing papers authored by Boris Brill
This map shows the geographic impact of Boris Brill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Brill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Brill more than expected).
Fields of papers citing papers by Boris Brill
This network shows the impact of papers produced by Boris Brill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Brill. The network helps show where Boris Brill may publish in the future.
Co-authors
The 25 scholars most cited alongside Boris Brill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 88 | |
| 2 | 2020 | 82 | |
| 3 | 2018 | 58 | |
| 4 | 2014 | 52 | |
| 5 | 2014 | 38 | |
| 6 | 2014 | 36 | |
| 7 | 2015 | 36 | |
| 8 | 2010 | 32 | |
| 9 | 2007 | 29 | |
| 10 | 2004 | 27 | |
| 11 | 2012 | 27 | |
| 12 | 2012 | 24 | |
| 13 | 2013 | 20 | |
| 14 | 2008 | 20 | |
| 15 | 2012 | 19 | |
| 16 | 2015 | 17 | |
| 17 | 2012 | 16 | |
| 18 | 2014 | 14 | |
| 19 | 2019 | 12 | |
| 20 | 2012 | 11 |
About Boris Brill
Boris Brill is a scholar working on Oncology, Immunology, Hematology, Cancer Research and Virology, having authored 36 papers that have together received 713 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (9 papers), Cancer Cells and Metastasis (4 papers), Immune Cell Function and Interaction (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Epigenetics and DNA Methylation (4 papers), T-cell and B-cell Immunology (4 papers), CAR-T cell therapy research (3 papers) and HIV Research and Treatment (3 papers). The work is most often cited by research in Virology (51 citations), Hematology (114 citations), Immunology (173 citations), Cancer Research (102 citations) and Oncology (166 citations). Boris Brill has collaborated with scholars based in Germany, United States and Israel. Frequent co-authors include Bernd Groner, Corina Borghouts, Vida Vafaizadeh, Ursula Dietrich, Judith Bergs, Franz Rödel, Anja Waldmann, Winfried S. Wels, Evelyn Ullrich and Sabine Huenecke. Their work appears in journals such as Hormone Molecular Biology and Clinical Investigation, Minerva Urology and Nephrology, Nutrients, Molecular Cancer Research and Pharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.